The nature of the heterogeneity of prothrombin during dicoumarol therapy.
D000596:Amino Acids / Q000032:analysis; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001780:Blood Coagulation Tests; D002849:Chromatography, Gas; D002852:Chromatography, Ion Exchange; D001728:Dicumarol / Q000494:pharmacology* / Q000627:therapeutic use; D004591:Electrophoresis, Polyacrylamide Gel; D005690:Galactose / Q000032:analysis; D005944:Glucosamine / Q000032:analysis; D005947:Glucose / Q000032:analysis; D006801:Humans; D007122:Immunoelectrophoresis; D008358:Mannose / Q000032:analysis; D009438:Neuraminic Acids / Q000032:analysis; D011516:Prothrombin / Q000032:analysis*
D000596:Amino Acids; D009438:Neuraminic Acids; D001728:Dicumarol; D011516:Prothrombin; D005947:Glucose; D005944:Glucosamine; D008358:Mannose; D005690:Galactose